Pakistan's Recommendations for Optimal Management of Diabetes from Primary to Tertiary care level (PROMPT)

被引:18
作者
Shera, A. Samad [1 ]
Basit, Abdul [2 ]
机构
[1] Diabet Assoc Pakistan, WHO Collaborating Ctr, Karachi, Pakistan
[2] Baqai Med Univ, Baqai Inst Diabetol & Endocrinol, Dept Med, Plot 1-2,II-B,Nazimabad 2, Karachi 74600, Pakistan
关键词
Diabetes guidelines; PROMPT; Referral criteria;
D O I
10.12669/pjms.335.13665
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pakistan is a developing country with limited resources and diverse socio-economic standards. Pakistan has high prevalence of diabetes and its complications, which is a great challenge to the existing health care system. National action plans for control of diabetes have been developed and initiatives have been taken but not at an ideal pace. First National Practice Guidelines for Pakistan were published in 1999. It was very helpful in standardizing the management of Type-2 diabetes. In view of important developments in the field of diabetes during the recent years, it was felt that 1999 National Clinical Practice Guidelines edited, should be revised. Also with rapidly increasing number of diabetic patients and the escalating burden on health economy, it is essential to develop a primary to secondary / tertiary care referral system. These guidelines are developed after an extensive research and cover many aspects of diabetes management. This special communication is an extract of a PROMPT document that has already been published as a Supplement in Pakistan Journal of Medical Sciences in 2017. We hope that these guidelines will help in improving the diabetes care in Pakistan.
引用
收藏
页码:1279 / 1283
页数:5
相关论文
共 8 条
  • [1] Clinical effect of metformin in children and adolescents with type 2 diabetes mellitus: A systematic review and meta-analysis
    Al-Shareef, Mohammed A.
    Sanneh, Abdoulie F. N. S.
    Aljoudi, Abdullah S.
    [J]. JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2012, 19 (02) : 68 - 73
  • [2] Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S011, 10.2337/dc12-s011, 10.2337/dc14-S081, 10.2337/dc13-S011]
  • [3] American Diabetes Association, 2011, Diabetes Care, V34 Suppl 1, pS4, DOI 10.2337/dc11-S004
  • [4] Basit A, 2014, PAK J MED SCI, V30, P1150, DOI 10.12669/pjms.305.6006
  • [5] Risk assessment of Pakistani individuals for diabetes (RAPID)
    Riaz, Musarrat
    Basit, Abdul
    Hydrie, Muhammad Zafar Iqbal
    Shaheen, Fariha
    Hussain, Akhtar
    Hakeem, Rubina
    Shera, Abdus Samad
    [J]. PRIMARY CARE DIABETES, 2012, 6 (04) : 297 - 302
  • [6] Rosenson Robert S, 2014, TREATMENT LIPIDS IN
  • [7] Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis
    Savage, M. W.
    Dhatariya, K. K.
    Kilvert, A.
    Rayman, G.
    Rees, J. A. E.
    Courtney, C. H.
    Hilton, L.
    Dyer, P. H.
    Hamersley, M. S.
    [J]. DIABETIC MEDICINE, 2011, 28 (05) : 508 - 515
  • [8] Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM
    Tatti, P
    Pahor, M
    Byington, RP
    Di Mauro, P
    Guarisco, R
    Strollo, G
    Strollo, F
    [J]. DIABETES CARE, 1998, 21 (04) : 597 - 603